Ganglioside complexes as targets for antibodies in Miller Fisher syndrome

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 77, Issue 9, 2006, Pages 1002-1003

  Willison, H J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CARBOHYDRATE; GANGLIOSIDE; GQ1B GANGLIOSIDE;

EDITORIAL; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOASSAY; IMMUNODETECTION; NERVOUS SYSTEM; PATHOGENESIS; PRIORITY JOURNAL; SCHWANN CELL; BLOOD; IMMUNOLOGY; NOTE; PATHOPHYSIOLOGY;

AUTOANTIBODIES; GANGLIOSIDES; HUMANS; MILLER FISHER SYNDROME;

EID: 33747428301     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2006.094441     Document Type: Editorial

References (6)

1. Chiba A, Kusunoki S, Obata H, et al. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 1993;43:1911-7.
2. Chiba A, Kusunoki S, Shimizu T, et al. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 1992;31:677-9.
3. Willison HJ. The immunobiology of Guillain-Barré syndromes. J Peripher Nerv Syst 2005;10:94-112.
4. Kaida K, Kanzaki M, Morita D, et al. Antiganglioside complex antibodies in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 2006;77:1043-6.
5. Kaida K, Morita D, Kanzaki M, et al. Ganglioside complexes as new target antigens in Guillain-Barré syndrome. Ann Neurol 2004;56:567-71.
6. Willison HJ. Ganglioside complexes: new autoantibody targets in Guillain-Barré syndromes. Nat Clin Pract Neurol 2004;1:2-3.